12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movement in Thursday's intraday session. LumiraDx (LMDX) saw a 42.8% increase, while Homology Medicines (FIXX) dropped 39.9%. Other notable gainers include Bone Biologics (BBLG), Impel Pharmaceuticals (IMPL), Iterum Therapeutics (ITRM), Apyx Medical (APYX), and Dermata Therapeutics (DRMA). On the losing side, MEI Pharma (MEIP), Augmedix (AUGX), SAB Biotherapeutics (SABS), PaxMedica (PXMD), and Syra Health (SYRA) saw declines. Volume spikes suggest increased investor interest, potentially due to recent Q3 earnings reports.

November 16, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apyx Medical shares increased by 20.13%, with trading volume exceeding the average, indicating positive investor sentiment.
The stock's price increase and higher volume suggest that the market is reacting favorably, which may continue in the short term.
CONFIDENCE 65
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Bone Biologics's stock increased by 26.55% with an exceptionally high trading volume following its Q3 earnings report.
The surge in price and volume after the Q3 earnings report suggests a positive investor reaction, which may lead to further short-term gains.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Dermata Therapeutics's stock moved up by 18.11%, with a significant increase in trading volume, indicating investor interest.
The notable uptick in price and volume could suggest a bullish trend that might persist in the short term.
CONFIDENCE 65
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Impel Pharmaceuticals shares increased by 25.04%, trading at a volume that far exceeds the average, indicating investor interest.
The significant increase in stock price and volume may attract more attention, potentially leading to continued short-term positive performance.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Iterum Therapeutics's stock rose 23.42% on high volume following its Q3 earnings release.
The stock's rise on increased volume post-earnings suggests a positive market response, which could lead to further short-term appreciation.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
LumiraDx shares soared 42.8% with a trading volume significantly higher than average, indicating strong investor interest.
The substantial rise in stock price and trading volume suggests positive investor sentiment, which could lead to continued short-term upward momentum.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Augmedix shares decreased by 20.45%, with a substantial rise in trading volume, indicating a bearish market sentiment.
The significant decrease in price accompanied by a high volume of trades could lead to further short-term negative pressure on the stock.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Homology Medicines stock plummeted by 39.9%, trading at a volume much higher than its average, reflecting negative market reaction.
The significant drop in stock price accompanied by a surge in volume typically indicates a strong bearish sentiment that may persist in the short term.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
MEI Pharma shares fell by 23.57%, with trading volume moderately above average, potentially due to market reaction to Q3 earnings.
The drop in stock price, along with increased volume, suggests a negative market reaction to recent earnings, which may affect short-term performance.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
PaxMedica shares fell by 15.3%, trading at a volume close to its average, indicating a moderate market reaction.
The stock's decline suggests a negative sentiment, but the close-to-average volume indicates a less dramatic market response, which may limit short-term impact.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
SAB Biotherapeutics's stock decreased by 16.81%, with trading volume exceeding average following its Q3 earnings report.
The decline in stock price and increased volume after earnings suggest a bearish outlook that may continue in the short term.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Syra Health's stock saw a 15.07% decrease, with market value reflecting a small cap size, potentially influenced by Q3 earnings.
The decrease in stock price post-earnings indicates a negative market reaction, which could impact short-term performance, especially given the small market cap.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 70